Holtz Children's Hospital
Miami, Florida, 33136, United States
NCT Number: NCT03695900
This is a prospective crossover study to compare the within-subject effect of the two target ranges of arterial oxygen saturation (SpO2), both within the clinically recommended range of 90- 95%. The specific objective of this study to evaluate the impact of targeting SpO2 within 93-95% compared to the 90-92% range on ventilatory stability in premature infants of 23-29 weeks gestational age (GA).
Looking for future studies?
Notify MeUp to 18 week
All sexes
Interventional
Not applicable
Miami, Florida, 33136, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
FiO2 adjusted to keep basal SpO2 at target range of 93-95% for 2 hours
FiO2 adjusted to keep basal SpO2 at target range of 90-92% for 2 hours.
Time frame: 2 hours
by frequency of central apnea
Time frame: 2 hours
by frequency of obstructive apnea
Time frame: 2 hours
by density of periodic breathing
Time frame: 2 hours
by time series of inter-breath intervals
Time frame: 2 hours
frequency of episodes with SpO2 < 80%
Time frame: 2 hours
frequency of episodes with HR < 100 bpm
University of Miami
Other
Impact of Arterial Oxygen Saturation Range on Ventilatory Stability in Extremely Premature Infants
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04123691
Apnea, Apnea of Prematurity
Bologna, Emilia-Romagna, Italy
View Trial DetailsNCT07552025
Apnea, Apnea of Prematurity
Montreal, Quebec, Canada
View Trial DetailsNCT07689669
Apnea, Apnea of Prematurity
Konya, Turkey (Türkiye)
View Trial DetailsNCT03651648
Apnea, Apnea of Prematurity
Rennes, France
View Trial Details